Literature DB >> 7567437

Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion.

B Drénou1, Y Le Tulzo, S Caulet-Maugendre, A Le Guerrier, C Leclercq, I Guilhem, N Lecoq, R Fauchet, R Thomas.   

Abstract

Certain neoplasias can induce unregulated erythropoietin (EPO) secretion which results in secondary erythrocytosis. Pheochromocytoma associated with erythrocytosis constitute a rare condition, where the secondary red cell abnormality is believed to be due to tumour EPO secretion. In one such case of pheochromocytoma related erythrocytosis, quantitative determination of serum EPO by enzyme immunoassay was combined with immunohistochemical examination of tumour tissue sections to locate the site of EPO secretion. EPO levels were initially high but decreased after tumour surgery, while immunolocalization showed EPO to be secreted by the neoplastic cells.

Entities:  

Mesh:

Year:  1995        PMID: 7567437

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  9 in total

1.  Transient ischaemic attack secondary to paraneoplastic erythrocytosis.

Authors:  Aldo René Hurtarte Sandoval; Bryan Josué Flores Robles; Robert Francis Andrus; David Alejandro Yaxcal Chon
Journal:  BMJ Case Rep       Date:  2014-10-21

2.  Intrahepatic cholestasis as a paraneoplastic syndrome associated with pheochromocytoma.

Authors:  C H Chung; C H Wang; C Y Tzen; C P Liu
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

3.  JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital.

Authors:  Katarzyna Aleksandra Jalowiec; Kristina Vrotniakaite-Bajerciene; Jakub Jalowiec; Noel Frey; Annina Capraru; Tatiana Wojtovicova; Raphael Joncourt; Anne Angelillo-Scherrer; Andre Tichelli; Naomi Azur Porret; Alicia Rovó
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

4.  Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis.

Authors:  M Todorovic; B Balint; N Suvajdzic; M Jevtic; M Pavlovic; M Petrovic; M Krstic; V Popovic; B Ivanovic; I Elezovic; R Milenkovic; M Colovic
Journal:  Med Oncol       Date:  2007-09-25       Impact factor: 3.064

5.  Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome.

Authors:  M Minetto; A Dovio; M Ventura; S Cappia; F Daffara; M Terzolo; A Angeli
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

6.  Pheochromocytoma Masquerading as "Diabetic Ketoacidosis".

Authors:  Jeffrey Stephen Hedley; Sidney Law; Sujoy Phookan; Maria Nien-Feng Lee; Adriana Ioachimescu; Rebecca D Levit
Journal:  J Investig Med High Impact Case Rep       Date:  2016-04-21

7.  Congestive heart failure and upper extremity deep vein thrombosis: A rare presentation of a pheochromocytoma.

Authors:  Eman M Alfadhli
Journal:  J Taibah Univ Med Sci       Date:  2020-05-01

Review 8.  MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma.

Authors:  Peter Istvan Turai; Gábor Nyírő; Henriett Butz; Attila Patócs; Peter Igaz
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

9.  Endocrine hypertension: An overview on the current etiopathogenesis and management options.

Authors:  Reena M Thomas; Ewa Ruel; Prapimporn Ch Shantavasinkul; Leonor Corsino
Journal:  World J Hypertens       Date:  2015
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.